Regencell Bioscience Holdings Ltd (RGC)
5.70
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
5.70
0.00 (0.00%)
After-Hours: 20:00
Regencell Bioscience Holdings Total Assets (Quarterly): 12.62M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 12.62M |
| December 31, 2022 | 15.55M |
| December 31, 2022 | 15.55M |
| June 30, 2022 | 18.02M |
| December 31, 2021 | 21.06M |
| Date | Value |
|---|---|
| December 31, 2021 | 21.06M |
| June 30, 2021 | 0.3401M |
| December 31, 2020 | 0.6004M |
| December 31, 2020 | 0.6004M |
| June 30, 2020 | 0.514M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3401M
Minimum
Jun 2021
21.06M
Maximum
Dec 2021
10.59M
Average
14.08M
Median
Total Assets (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.6323M |
| Shareholders Equity (Quarterly) | 12.03M |